From aging to cancer: a DNA methylation journey
Ageing Research · 2012
DOI: 10.4081/ar.2012.e4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ageing Research, 2012. Verfasst von Natalia Puig und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Epigenetic gene silencing through DNA promoter hypermethylation is now recognised as a major step in the neoplastic transformation of the cell. The methylation levels of several genes increase with age in normal tissues such as the prostate or colon. Genes like WRN or LMNA that are involved in progeria,a premature aging disease WRN and LMNA, are epigenetically inactivated in cancer. In both aging and cancer, global DNA methylation decreases, potentially accounting for the characteristic genomic instability of these processes. In this review, we will focus on how the accumulation of changes in DNA methylation during aging impact tumourigenesis.
Zitieren
APA
Puig, N., & Agrelo, R. (2012). From aging to cancer: a DNA methylation journey. Ageing Research. https://doi.org/10.4081/ar.2012.e4
Vancouver
Puig N, Agrelo R. From aging to cancer: a DNA methylation journey. Ageing Research. 2012. doi:10.4081/ar.2012.e4
BibTeX
@article{Puig2012,
author = {Puig, Natalia and Agrelo, Ruben},
title = {From aging to cancer: a DNA methylation journey},
journal = {Ageing Research},
year = {2012},
doi = {10.4081/ar.2012.e4}
}
EUVIMED